/Companies

Elute

1 known investors

Find your way into Elute

Elut is a clinical-stage medical device company developing patented drug-eluting devices that provide controlled, sustained therapeutic release, with a current focus on treating orthopedic and periprosthetic joint infections. Its technology is applied to bone void fillers that deliver local antibiotics over an eight-week period.

Investors · 1

Frequently asked questions

What does Elute do?
Elut is a clinical-stage medical device company developing patented drug-eluting devices that provide controlled, sustained therapeutic release, with a current focus on treating orthopedic and periprosthetic joint infections. Its technology is applied to bone void fillers that deliver local antibiotics over an eight-week period.
Who are Elute's investors?
Elute's investors include UpStart Ventures.